Parag Kumar

2.5k total citations
43 papers, 1.2k citations indexed

About

Parag Kumar is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Parag Kumar has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Parag Kumar's work include HIV/AIDS drug development and treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Parag Kumar is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Parag Kumar collaborates with scholars based in United States, Singapore and Greece. Parag Kumar's co-authors include Kristina M. Brooks, Deborah P. Merke, Ashwini Mallappa, Ninet Sinaii, Kevin Laliberte, Jomy George, Robert Evers, L. Henry Bryant, David A. Bluemke and Ashkan A. Malayeri and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Parag Kumar

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Parag Kumar United States	18	285	238	217	194	160	43	1.2k
Raphaël Duivenvoorden Netherlands	22	315 1.1×	150 0.6×	183 0.8×	417 2.1×	193 1.2×	50	1.7k
Patricia Guevara‐Ramírez Ecuador	22	409 1.4×	75 0.3×	82 0.4×	191 1.0×	214 1.3×	83	1.5k
David G. Grenache United States	24	327 1.1×	99 0.4×	107 0.5×	187 1.0×	143 0.9×	87	1.7k
Long Shen China	25	295 1.0×	125 0.5×	174 0.8×	218 1.1×	119 0.7×	79	1.6k
Yongqing Tong China	21	354 1.2×	110 0.5×	44 0.2×	189 1.0×	151 0.9×	58	1.2k
Renée M. Ned United States	18	296 1.0×	71 0.3×	110 0.5×	184 0.9×	104 0.7×	31	1.3k
Gilad Halpert Israel	14	205 0.7×	293 1.2×	45 0.2×	151 0.8×	66 0.4×	35	1.0k
Erik M. van Maarseveen Netherlands	20	206 0.7×	176 0.7×	33 0.2×	153 0.8×	101 0.6×	52	1.2k
Carmen Fernández‐Merino Spain	9	175 0.6×	71 0.3×	65 0.3×	229 1.2×	107 0.7×	19	712
Pi‐Yueh Chang Taiwan	23	398 1.4×	107 0.4×	70 0.3×	149 0.8×	277 1.7×	68	1.4k

Countries citing papers authored by Parag Kumar

Since Specialization

Citations

This map shows the geographic impact of Parag Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parag Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parag Kumar more than expected).

Fields of papers citing papers by Parag Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parag Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parag Kumar. The network helps show where Parag Kumar may publish in the future.

Co-authorship network of co-authors of Parag Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Parag Kumar. A scholar is included among the top collaborators of Parag Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parag Kumar. Parag Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grundmann, Oliver, Parag Kumar, & Mark Rogge. (2021). Regulation of Dietary Supplements and Nutraceutical Products in the United States: An Argument for Greater Oversight and Uniform Standards. The Journal of Clinical Pharmacology. 62(1). 14–16. 7 indexed citations

Rogge, Mark, Parag Kumar, & Oliver Grundmann. (2021). Front‐Line Health Care Professionals Lack Critical Knowledge in Dietary Supplement and Nutraceutical Products: A Call to Action for Comprehensive Educational Opportunities. The Journal of Clinical Pharmacology. 62(1). 17–19. 5 indexed citations

Hughes, Thomas E., et al.. (2020). A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD. Bone Marrow Transplantation. 55(6). 1085–1092. 3 indexed citations

Pai, Sudhakar M., Ahmed A. Othman, Joanna C. Masters, et al.. (2020). Science and Evidence‐Based Review and Approval of COVID‐19 Vaccines: A Statement of Support for the US FDA. The Journal of Clinical Pharmacology. 61(3). 277–279. 6 indexed citations

Kumar, Parag, et al.. (2019). Atypical Presentation of Viral Gastroenteritis in a Three-year-old Child Due to a UNC80 Mutation. Cureus. 11(4). e4395–e4395. 3 indexed citations

Kumar, Parag, Andrew T. Lucas, David A. Barrow, et al.. (2018). Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients. Cancer Chemotherapy and Pharmacology. 83(1). 61–70. 11 indexed citations

Penzak, Scott, et al.. (2018). Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood–Cerebrospinal Fluid Barrier and Blood–Brain Barrier. European Journal of Drug Metabolism and Pharmacokinetics. 43(6). 619–635. 4 indexed citations

Beigel, John H., Jocelyn Voell, Parag Kumar, et al.. (2018). Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. The Lancet Infectious Diseases. 18(4). 410–418. 86 indexed citations

Kumar, Parag, Michail S. Lionakis, Amanda Urban, et al.. (2018). 1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies. Open Forum Infectious Diseases. 5(suppl_1). S435–S435. 10 indexed citations

10.

Kumar, Parag, et al.. (2016). A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration. Clinical Pharmacokinetics. 55(12). 1495–1505. 51 indexed citations

11.

Malayeri, Ashkan A., Kristina M. Brooks, L. Henry Bryant, et al.. (2016). National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain. Journal of the American College of Radiology. 13(3). 237–241. 85 indexed citations

12.

Giovinazzo, Hugh, Parag Kumar, Arif Sheikh, et al.. (2016). Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemotherapy and Pharmacology. 77(3). 565–573. 19 indexed citations

13.

Penzak, Scott, et al.. (2016). Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects. Clinical Infectious Diseases. 62(8). 1036–1042. 9 indexed citations

14.

Nella, Aikaterini A., Ashwini Mallappa, Verena Gounden, et al.. (2016). A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 101(12). 4690–4698. 59 indexed citations

15.

Mallappa, Ashwini, Ninet Sinaii, Parag Kumar, et al.. (2014). A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 100(3). 1137–1145. 106 indexed citations

16.

Kumar, Parag, et al.. (2013). Lack of a Pharmacokinetic Interaction Between Treprostinil Diolamine and Sildenafil in Healthy Adult Volunteers. Journal of Cardiovascular Pharmacology. 61(5). 444–451. 10 indexed citations

17.

Lay, John C., Alan M. Fong, Ninh M. La‐Beck, et al.. (2013). Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal Pharmacology. Journal of Pharmacology and Experimental Therapeutics. 347(3). 599–606. 58 indexed citations

18.

Buck, Brian, et al.. (2013). Community-Acquired Pneumonia with Risk for Drug-Resistant Pathogens. Southern Medical Journal. 106(3). 209–216. 7 indexed citations

19.

Kumar, Parag & David Rowbotham. (2012). P330 Cyclosporin A as rescue therapy for steroid-refractory acute severe ulcerative colitis: Oral administration is as effective as intravenous. Journal of Crohn s and Colitis. 6. S141–S141. 1 indexed citations

20.

Kumar, Parag, et al.. (2012). Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents. Clinical Pharmacology & Therapeutics. 91(5). 802–812. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact